Digital healthcare platform MediBuddy reported operating revenue of ₹724.6 crore in FY25, marking a 12.3% year-on-year growth from ₹645.4 crore in FY24, even as the company focused on improving efficiency and reducing losses. Despite slower growth compared to the previous year’s rapid expansion, MediBuddy managed to narrow its net loss by 37% during the fiscal year ended March 2025.
According to financial statements filed with the Registrar of Companies (RoC), MediBuddy’s core healthcare services including online and offline doctor consultations, medicine delivery, diagnostic tests, surgeries, and insurance services continued to be its primary revenue drivers, contributing ₹722 crore in FY25. Other operating income stood at ₹2.5 crore. Including ₹18.42 crore in non-operating income, largely from interest and miscellaneous sources, the company’s total income rose to ₹743 crore for the year.
Expenses Remain Flat, Margins Improve
On the cost side, total expenses remained largely flat at ₹879 crore in FY25, reflecting tighter cost controls. Cost of materials formed the largest expense component at ₹333 crore, accounting for nearly 38% of overall expenditure. Employee benefit expenses rose modestly by 8% to ₹176.8 crore, including ₹6 crore in ESOP costs.
Sales payout expenses declined 7% to ₹155.47 crore, while spending on safety and security stood at ₹42.5 crore and information technology costs were ₹32.5 crore. Other overheads, including legal fees, advertising, depreciation, and finance costs, amounted to ₹138.7 crore.
Losses Narrow, EBITDA Improves
Controlled spending and steady revenue growth helped MediBuddy reduce its net loss to ₹137 crore in FY25, compared with ₹215.7 crore in FY24. The company’s EBITDA margin improved significantly to -14.19% from -25.67%, with EBITDA losses declining to ₹103 crore. On a unit basis, MediBuddy spent ₹1.21 to earn every rupee of operating revenue.
As of March 2024, the Bengaluru-based firm reported current assets of ₹395.2 crore, including cash and bank balances of ₹80 crore, providing it with adequate liquidity as it continues its path toward profitability.
Follow Startupbydoc for daily startup insights, funding news, IPO analysis, and business breakdowns.